• Return to Headlines

Incyte Corp: The Winning Streak Continues (INCY)

By Amy Schwartz

Incyte Corp (NASDAQ:INCY) traded today at a new 52-week high of $104.81. So far today approximately 188,000 shares have been exchanged, as compared to an average 30-day volume of 2.4 million shares.

Incyte Corp (NASDAQ:INCY) is currently priced 19.7% above its average consensus analyst price target of $83.75. Incyte Corp shares have support at the 200-day moving average (MA) of $81.36 and additional support at the 50-day MA of $79.97.

Incyte Corp share prices have moved between a 52-week high of $104.81 and a 52-week low of $62.48 and are now trading 67% above that low price at $104.25 per share. Over the past week, the 200-day moving average (MA) has gone up 0.5% while the 50-day MA has advanced 3.4%.

Incyte Corporation is a biopharmaceutical company. The Company discovers, develops, and commercializes proprietary small molecule drugs, primarily used in oncology.

SmarTrend is tracking the current trend status for Incyte Corp and will alert subscribers who have INCY in their portfolio or watchlist when shares have changed trend direction.

Keywords: 52 week high/lows incyte corp

Ticker(s): INCY